Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences

Clinical Infectious Diseases

Volumn 34, Issue 8, 2002, Pages 1108-1114

  Blackard, Jason T ^a   Cohen, Daniel E ^a   Mayer, Kenneth H ^b  

^a Research and Evaluation Department   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

FORECASTING; HIV; HIV INFECTIONS; HUMANS; RECOMBINATION, GENETIC; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VARIATION (GENETICS);

EID: 0037090059     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339547     Document Type: Article

References (61)

1. Human immunodeficiency viruses in the developing world
2. HIV-1 subtypes and male-to-female transmission in Thailand
3. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya
4. Viral load differences in early infection with two HIV-1 subtypes
5. Human immunodeficiency virus type 1 subtypes differ in disease progression
6. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
7. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
8. Differences in perinatal transmission between HIV-1 genotypes
9. Elevated tumor necrosis factor-α activation of human immunodeficiency virus type 1 subtype C in southern Africa is associated with an NF-κB enhancer gain-of-function
10. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G
11. Understanding the genetic diversity of HIV-1
12. Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection
13. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development
14. Direct demonstration of retroviral recombination in a rhesus monkey
15. High rate of recombination throughout the human immunodeficiency virus type 1 genome
16. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon
17. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient
18. Mosaic genome structure of simian immunodeficiency virus from West African green monkeys
19. Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus
20. Recombination in HIV-1
21. Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC
22. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure
23. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance
24. Sharp genetic diversity of HIV-1: The moving target
25. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries
26. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States
27. Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States
28. Transcriptional effects of superinfection in HIV chronically infected T cells: Studies in dually infected clones
29. Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells
30. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers
31. Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS
32. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model
33. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression
34. Genetic analysis of HIV type 1 in monotypic and dual HIV infections
35. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa
36. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: Significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection
37. Dual infection with human immunodeficiency virus type 1 and type 2: Impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast
38. Natural protection against HIV-1 infection provided by HIV-2
39. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2
40. Triple HIV-1 infection with group O and group M of different clades in a single Cameroonian AIDS patient
41. Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women
42. Dual and recombinant infections: An integral part of the HIV-1 epidemic in Brazil
43. HIV-1 genetic diversity in Galicia, Spain: BG intersubtype recombinant viruses circulating among infecting drug users
44. Gender differences in HIV-1 diversity at time of infection
45. Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women
46. In vivo sequence variation of the human immunodeficiency virus type 1 env gene: Evidence for recombination among variants found in a single individual
47. Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence of double infection
48. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconverter
49. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient
50. Dual infection with different strains of the same HIV-1 subtype
51. Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism
52. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex
53. Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices
54. Very young gay and bisexual men are at risk for HIV infection: The San Francisco Bay Area Young Men's Study II
55. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status
56. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
57. Births and deaths: Preliminary data for July 1997-June 1998
58. Documentation of HIV-1 superinfection and acceleration of disease progression
59. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
60. Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study
61. Sexual transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors